Clinical Trial Update: Experimental Vaccine for Plasmodium Falciparum Malaria [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 clinical trial of an experimental vaccine targeting Plasmodium falciparum malaria, sponsored by NIAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Experimental vaccine for Plasmodium falciparum malaria

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Malaria, Vaccines | Phase 1 | Status: COMPLETED